The pathogenesis of diabetic retinopathy: old concepts and new questions

Hyperglycaemia appears to be a critical factor in the aetiology of diabetic retinopathy and initiates downstream events including: basement membrane thickening, pericyte drop out and retinal capillary non-perfusion. More recently, focus has been directed to the molecular basis of the disease process in diabetic retinopathy. Of particular importance in the development and progression of diabetic retinopathy is the role of growth factors (eg vascular endothelial growth factor, placenta growth factor and pigment epithelium-derived factor) together with specific receptors and obligate components of the signal transduction pathway needed to support them. Despite these advances there are still a number of important questions that remain to be answered before we can confidently target pathological signals. How does hyperglycaemia regulate retinal vessels? Which growth factors are most important and at what stage of retinopathy do they operate? What is the preferred point in the growth factor signalling cascade for therapeutic intervention? Answers to these questions will provide the basis for new therapeutic interventions in a debilitating ocular condition.

[1]  G. Viglietto,et al.  Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[2]  L. Feld,et al.  Degenerated intramural pericytes ('ghost cells') in the retinal capillaries of diabetic rats. , 1991, Current eye research.

[3]  T. Resink,et al.  Activation of phospholipase A2 by endothelin in cultured vascular smooth muscle cells. , 1989, Biochemical and biophysical research communications.

[4]  E. Kohner,et al.  A two-year follow-up study of serum insulinlike growth factor-I in diabetics with retinopathy. , 1989, Metabolism: clinical and experimental.

[5]  D. Fulton,et al.  Pharmacological evaluation of an epoxide as the putative hyperpolarizing factor mediating the nitric oxide-independent vasodilator effect of bradykinin in the rat heart. , 1998, The Journal of pharmacology and experimental therapeutics.

[6]  J. Folkman,et al.  Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy , 1995 .

[7]  M. Lorenzi,et al.  Early biosynthetic changes in the diabetic-like retinopathy of galactose-fed rats , 1996, Diabetologia.

[8]  A. Yoshida,et al.  Retinal blood flow alterations during progression of diabetic retinopathy. , 1983, Archives of ophthalmology.

[9]  S. Weiss,et al.  Insulin-Like Growth Factor-I Is Necessary for Neural Stem Cell Proliferation and Demonstrates Distinct Actions of Epidermal Growth Factor and Fibroblast Growth Factor-2 , 2001, The Journal of Neuroscience.

[10]  K. Miyarnoto Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition , 1999 .

[11]  V. Roginsky,et al.  Superoxide dismutase inhibits lipid peroxidation in micelles. , 2001, Chemistry and physics of lipids.

[12]  A. Ljubimov,et al.  Basement membrane and growth factor gene expression in normal and diabetic human retinas. , 1999, Current eye research.

[13]  L. Cantley,et al.  HGF-mediated chemotaxis and tubulogenesis require activation of the phosphatidylinositol 3-kinase. , 1995, The American journal of physiology.

[14]  N. Ferrara,et al.  Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. , 1989, Biochemical and biophysical research communications.

[15]  C. Ferrario,et al.  Losartan inhibits thromboxane A2-induced platelet aggregation and vascular constriction in spontaneously hypertensive rats. , 1998, Journal of cardiovascular pharmacology.

[16]  W. Li,et al.  Altered mRNA levels of antioxidant enzymes in pre-apoptotic pericytes from human diabetic retinas. , 1999, Cellular and molecular biology.

[17]  K. Shimoke,et al.  Differences in survival‐promoting effects and intracellular signaling properties of BDNF and IGF‐1 in cultured cerebral cortical neurons , 2001, Journal of neurochemistry.

[18]  L. Claesson‐Welsh,et al.  VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase. , 2001, Experimental cell research.

[19]  J. García-Campos,et al.  Effect of WEB 2086-BS, an antagonist of platelet-activating factor receptors, on retinal vascularity in diabetic rats. , 1998, European journal of pharmacology.

[20]  Yihai Cao,et al.  Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-γ and migration of endothelial cells expressing Flt 1 , 1998, Oncogene.

[21]  L. Aiello,et al.  Vascular Endothelial Growth Factor Induces Expression of Connective Tissue Growth Factor via KDR, Flt1, and Phosphatidylinositol 3-Kinase-Akt-dependent Pathways in Retinal Vascular Cells* , 2000, The Journal of Biological Chemistry.

[22]  Thomas N. Sato,et al.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.

[23]  P. Pratt,et al.  Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. , 1996, Circulation research.

[24]  H. Suzuki,et al.  Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes , 1997, Diabetologia.

[25]  N. Hotta,et al.  Aldose reductase inhibition prevents glucose-induced apoptosis in cultured bovine retinal microvascular pericytes. , 2000, Experimental eye research.

[26]  N. Morisaki,et al.  Migratory and proliferative effect of platelet‐derived growth factor in rabbit retinal endothelial cells: Evidence of an autocrine pathway of platelet‐derived growth factor , 1994, Journal of cellular physiology.

[27]  R. Kawamori,et al.  Clinical usefulness of measuring urinary polyol excretion by gas-chromatography/mass-spectrometry in type 2 diabetes to assess polyol pathway activity. , 2001, Diabetes research and clinical practice.

[28]  A. Garner Histopathology of diabetic retinopathy in man , 1993, Eye.

[29]  M. Neider,et al.  Cystoid macular degeneration in experimental branch retinal vein occlusion. , 1988, Ophthalmology.

[30]  B. Williams Vascular Permeability/Vascular Endothelial Growth Factors: A Potential Role in the Pathogenesis and Treatment of Vascular Diseases , 1996, Vascular medicine.

[31]  A. Laties Central retinal artery innervation. Absence of adrenergic innervation to the intraocular branches. , 1967, Archives of ophthalmology.

[32]  D. Faller,et al.  Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells. , 1990, The Journal of clinical investigation.

[33]  G. King,et al.  d-Alpha-tocopherol prevents the hyperglycemia induced activation of diacylglycerol (DAG)-protein kinase C (PKC) pathway in vascular smooth muscle cell by an increase of DAG kinase activity. , 1999, Diabetes research and clinical practice.

[34]  J. Nourooz-Zadeh,et al.  F2 Isoprostanes, Potential Specific Markers of Oxidative Damage in Human Retina , 2000, Ophthalmic Research.

[35]  F. Ismail-Beigi,et al.  Diabetes downregulates GLUT1 expression in the retina and its microvessels but not in the cerebral cortex or its microvessels. , 2000, Diabetes.

[36]  Dajun Yang,et al.  Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells. , 1999, Microvascular research.

[37]  S. Oparil,et al.  Endothelial dysfunction in the pulmonary vascular bed. , 2000, The American journal of the medical sciences.

[38]  Z. Katušić,et al.  Superoxide anion is an endothelium-derived contracting factor. , 1989, The American journal of physiology.

[39]  S. Ryu,et al.  The mechanism of phospholipase C-γ1 regulation , 2000, Experimental & Molecular Medicine.

[40]  T. Lüscher,et al.  Endothelium-dependent Vasoactive Modulation in the Ophthalmic Circulation , 2001, Progress in Retinal and Eye Research.

[41]  H. Kleinman,et al.  Scatter factor induces blood vessel formation in vivo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[42]  H Ueno,et al.  The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. , 1992, Science.

[43]  E. Kohner,et al.  Serum IGF‐1 Concentration in Diabetic Retinopathy , 1988, Diabetic medicine : a journal of the British Diabetic Association.

[44]  M. Lizak,et al.  Polyol formation and NADPH-dependent reductases in dog retinal capillary pericytes and endothelial cells. , 1999, Investigative ophthalmology & visual science.

[45]  N. Ferrara,et al.  Role of Vascular Endothelial Growth Factor in Regulation of Angiogenesis , 1999 .

[46]  I. Morita,et al.  Stimulatory effects of insulin and insulin-like growth factor I on migration and tube formation by vascular endothelial cells. , 1992, Atherosclerosis.

[47]  N. Bouck,et al.  Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[48]  G. King,et al.  Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. , 1994, The American journal of physiology.

[49]  A. Kumagai,et al.  Enhancement of glucose transport by vascular endothelial growth factor in retinal endothelial cells. , 2000, Investigative ophthalmology & visual science.

[50]  Y. Chung,et al.  IGF-I of serum and vitreous fluid in patients with diabetic proliferative retinopathy. , 1994, Diabetes research and clinical practice.

[51]  M. Boulton,et al.  Increased expression of placenta growth factor in proliferative diabetic retinopathy. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[52]  S. Husain,et al.  Endothelin-1 activates p38 mitogen-activated protein kinase and cytosolic phospholipase A2 in cat iris sphincter smooth muscle cells. , 1999, The Biochemical journal.

[53]  R. Heller,et al.  Nitrovasodilators inhibit thrombin-induced platelet-activating factor synthesis in human endothelial cells. , 1992, Biochemical pharmacology.

[54]  S. Moncada,et al.  Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in platelets , 1987, British journal of pharmacology.

[55]  P. Pratt,et al.  Bioassay of an Endothelium-Derived Hyperpolarizing Factor from Bovine Coronary Arteries: Role of a Cytochrome P450 Metabolite , 1998, Journal of Vascular Research.

[56]  S. Nicosia,et al.  Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. , 1994, The American journal of pathology.

[57]  R. Michels,et al.  Diabetic preretinal membranes. An immunohistochemical study. , 1986, Archives of ophthalmology.

[58]  K. Suzuma,et al.  Hypoxia and Vascular Endothelial Growth Factor Selectively Up-regulate Angiopoietin-2 in Bovine Microvascular Endothelial Cells* , 1999, The Journal of Biological Chemistry.

[59]  P. Braquet,et al.  Presence of specific platelet-activating factor binding sites in the rat retina. , 1989, European journal of pharmacology.

[60]  Dao-Yi Yu,et al.  Proceedings of the Australian Physiological and Pharmacological Society Symposium: Diabetes DIABETIC RETINOPATHY EARLY FUNCTIONAL CHANGES , 2006 .

[61]  C. Abrass,et al.  Phenotypic Expression of Collagen Types in Mesangial Matrix of Diabetic and Nondiabetic Rats , 1988, Diabetes.

[62]  Joan W. Miller,et al.  Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. , 1996, Ophthalmology.

[63]  J. Ji Pigment epithelium derived factor:a potent inhibitor of angiogenesis , 2002 .

[64]  Pamela F. Jones,et al.  Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.

[65]  S. Basili,et al.  Polyol pathway activation and glutathione redox status in non-insulin-dependent diabetic patients. , 1997, Metabolism: clinical and experimental.

[66]  E. Araki,et al.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. , 1995, Diabetes research and clinical practice.

[67]  A. Camm,et al.  New class III antiarrhythmic drugs. , 1993, European heart journal.

[68]  G. King,et al.  Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[69]  R. Eddy,et al.  Identification of a new endothelial cell growth factor receptor tyrosine kinase. , 1991, Oncogene.

[70]  Alan W. Stitt,et al.  Advanced glycation: an important pathological event in diabetic and age related ocular disease , 2001, The British journal of ophthalmology.

[71]  L. Aiello,et al.  Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth. , 2000, Investigative ophthalmology & visual science.

[72]  S. Cringle,et al.  Overview of studies on metabolic and vascular regulatory changes in early diabetic retinopathy. , 1998, Australian and New Zealand journal of ophthalmology.

[73]  H Shimokawa,et al.  Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. , 2000, The Journal of clinical investigation.

[74]  H. Flynn,et al.  Echographic evaluation of a patient with diabetes and dense vitreous hemorrhage: an avulsed retinal vessel may mimic a tractional retinal detachment. , 2001, American journal of ophthalmology.

[75]  Marlys Witte,et al.  Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells , 1998, International journal of cancer.

[76]  P. Kubes,et al.  Leukocyte-induced vascular protein leakage in cat mesentery. , 1991, The American journal of physiology.

[77]  G. Zimmerman,et al.  Endothelial cell interactions with granulocytes: tethering and signaling molecules. , 1992, Immunology today.

[78]  Philippe Soriano,et al.  Growth factor signaling pathways in vascular development , 1999, Oncogene.

[79]  T. Yamane,et al.  Activation of Human Neutrophil by Cytokine-Activated Endothelial Cells , 2001, Circulation research.

[80]  J. Brugge,et al.  Tyrosine phosphorylation and cytoskeletal reorganization in platelets are triggered by interaction of integrin receptors with their immobilized ligands. , 1993, The Journal of biological chemistry.

[81]  M. Matsumoto,et al.  Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[82]  M. Cooper,et al.  Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[83]  T. Nishikawa,et al.  Changes in diabetic retinal matrix protein mRNA levels in a common transgenic mouse strain , 2000 .

[84]  Alan W. Stitt,et al.  Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients. , 1995, The British journal of ophthalmology.

[85]  D. Foreman,et al.  VEGF localisation in diabetic retinopathy , 1998, The British journal of ophthalmology.

[86]  S. Chakrabarti,et al.  Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy , 2000, Diabetes/metabolism research and reviews.

[87]  A Mathis,et al.  Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. , 1994, Archives of ophthalmology.

[88]  K. Tracey,et al.  Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. , 1991, The Journal of clinical investigation.

[89]  P. Campochiaro,et al.  Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. , 1999, Investigative ophthalmology & visual science.

[90]  T. Lüscher,et al.  Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor. , 1991, Circulation.

[91]  S. Moncada,et al.  EFFECTS OF ENDOTHELIUM-DERIVED NITRIC OXIDE ON PERIPHERAL ARTERIOLAR TONE IN MAN , 1989, The Lancet.

[92]  M. Corada,et al.  Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. , 1998, Journal of cell science.

[93]  W. Li,et al.  Retinal capillary pericyte apoptosis in early human diabetic retinopathy. , 1997, Chinese medical journal.

[94]  E. F. Kern,et al.  Effects of Polyol-Pathway Inhibition and Dietary myo-Inositol on Glomerular Hemodynamic Function in Experimental Diabetes Mellitus in Rats , 1991, Diabetes.

[95]  J. Rubin,et al.  Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. , 1991, Science.

[96]  H. Hammes,et al.  Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. , 2001, Diabetes.

[97]  M. Matsumura,et al.  Epiretinal membrane of proliferative diabetic retinopathy: an immunohistochemical study. , 1993, Ophthalmic research.

[98]  F. Ferris,et al.  Diabeteslike proliferative retinal changes in galactose-fed dogs. , 1995, Archives of ophthalmology.

[99]  M. Nelson,et al.  Extracellular K(+)‐induced hyperpolarizations and dilatations of rat coronary and cerebral arteries involve inward rectifier K(+) channels. , 1996, The Journal of physiology.

[100]  D. Killilea,et al.  Hypoxia promotes oxidative base modifications in the pulmonary artery endothelial cell VEGF gene , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[101]  M. Dunlop,et al.  Aldose reductase and the role of the polyol pathway in diabetic nephropathy. , 2000, Kidney international. Supplement.

[102]  N. Ashton Retinal vascularization in health and disease: Proctor Award Lecture of the Association for Research in Ophthalmology. , 1957, American journal of ophthalmology.

[103]  Paul Kubes,et al.  The microcirculation and inflammation: modulation of leukocyte‐endothelial cell adhesion , 1994, Journal of leukocyte biology.

[104]  S. Bursell,et al.  Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. , 1997, American journal of ophthalmology.

[105]  H. Bohlen,et al.  Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilation of normal rat arterioles. , 1993, The American journal of physiology.

[106]  D. Hinton,et al.  Retinal pigment epithelial cells secrete and respond to hepatocyte growth factor. , 1998, Biochemical and biophysical research communications.

[107]  K. Nakagawa,et al.  The mechanism of thrombin-induced prostacyclin synthesis in human endothelial cells with reference to the gene transcription of prostacyclin-related enzymes and Ca2+ kinetics. , 1999, Journal of pharmacological and toxicological methods.

[108]  E. Sage,et al.  PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors , 1994, The Journal of cell biology.

[109]  T. Onat,et al.  Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control. , 2001, Archives of medical research.

[110]  E. Elson,et al.  Mechanics of stimulated neutrophils: cell stiffening induces retention in capillaries. , 1989, Science.

[111]  L. Aiello,et al.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.

[112]  P. Campochiaro,et al.  Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization. , 1998, The American journal of pathology.

[113]  Y. Yazaki,et al.  Vascular Smooth Muscle Cell-Directed Overexpression of Heme Oxygenase-1 Elevates Blood Pressure Through Attenuation of Nitric Oxide-Induced Vasodilation in Mice , 2001, Circulation research.

[114]  A. Ceriello Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications. , 1999, Diabetes, nutrition & metabolism.

[115]  R. Khalifah,et al.  Amadorins: novel post-Amadori inhibitors of advanced glycation reactions. , 1999, Biochemical and biophysical research communications.

[116]  W. Daughaday,et al.  Endogenous insulin-like growth factor (IGF) binding proteins cause IGF-1 resistance in cultured fibroblasts from a patient with short stature. , 1991, The Journal of clinical investigation.

[117]  J. van de Voorde,et al.  Endothelial dysfunction in diabetes , 2000, British journal of pharmacology.

[118]  M. Lorenzi,et al.  Increased prevalence of microthromboses in retinal capillaries of diabetic individuals. , 2001, Diabetes.

[119]  M. Shimura,et al.  Quantifying leukocyte dynamics and plugging in retinal microcirculation of streptozotosin-induced diabetic rats. , 1999, Current eye research.

[120]  R. Busse,et al.  Characterization of endothelium‐derived hyperpolarizing factor as a cytochrome P450‐derived arachidonic acid metabolite in mammals. , 1994, The Journal of physiology.

[121]  T. Kern,et al.  Vascular lesions in diabetes are distributed non-uniformly within the retina , 1995 .

[122]  M. Derwahl,et al.  Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy. , 2000, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[123]  I. Fleming,et al.  Cytochrome P450 2C is an EDHF synthase in coronary arteries. , 2000, Trends in cardiovascular medicine.

[124]  M. Goldberg,et al.  Transcriptional Regulation of the Rat Vascular Endothelial Growth Factor Gene by Hypoxia (*) , 1995, The Journal of Biological Chemistry.

[125]  N. Karmakar Interaction of transmural pressure and shear stress in the transport of albumin across the rabbit aortic wall. , 2001, Atherosclerosis.

[126]  M. Li,et al.  Enhanced shear-induced von Willebrand factor binding to platelets in acute myocardial infarction. , 2000, Thrombosis research.

[127]  J. Erusalimsky,et al.  Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. , 1995, Circulation.

[128]  F. Wen,et al.  Eicosanoid profile in cultured human pulmonary artery smooth muscle cells treated with IL-1 beta and TNF alpha. , 1998, Prostaglandins, Leukotrienes and Essential Fatty Acids.

[129]  L. Claesson-Welsh,et al.  Platelet-derived growth factor receptor signals. , 1994, The Journal of biological chemistry.

[130]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[131]  T. Kern,et al.  Abnormalities of Retinal Metabolism in Diabetes or Experimental Galactosemia. III. Effects of Antioxidants , 1996, Diabetes.

[132]  T. Kern,et al.  Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. , 1997, Free radical biology & medicine.

[133]  G. Brown,et al.  Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. , 1990, Archives of ophthalmology.

[134]  J. Isner,et al.  Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. , 1998, Circulation.

[135]  D. K. Ways,et al.  The role of protein kinase C in the development of the complications of diabetes. , 2000, Vitamins and hormones.

[136]  J. Remacle,et al.  Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions. , 2000, Biochimica et biophysica acta.

[137]  D. Eliott,et al.  Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. , 1997, Investigative ophthalmology & visual science.

[138]  T. Bek,et al.  Glycoprotein deposition in vascular walls of diabetic retinopathy. A histopathological and immunohistochemical study. , 2009, Acta ophthalmologica Scandinavica.

[139]  S. Narayanan Aldose reductase and its inhibition in the control of diabetic complications. , 1993, Annals of clinical and laboratory science.

[140]  H. Yamashita,et al.  Expression of placenta growth factor (PIGF) in ischaemic retinal diseases , 1999, Eye.

[141]  L. Cantley,et al.  The tyrosine-phosphorylated hepatocyte growth factor/scatter factor receptor associates with phosphatidylinositol 3-kinase. , 1991, The Journal of biological chemistry.

[142]  P. Gruppuso,et al.  Src family tyrosine kinases participate in insulin-like growth factor I mitogenic signaling in 3T3-L1 cells. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[143]  D. Foreman,et al.  Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy , 1999, The British journal of ophthalmology.

[144]  H. Zhu,et al.  Oxygen sensing and signaling: impact on the regulation of physiologically important genes. , 1999, Respiration physiology.

[145]  M. Dehouck,et al.  Endothelin-1 as a Mediator of Endothelial Cell–Pericyte Interactions in Bovine Brain Capillaries , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[146]  H. Oğuz,et al.  The role of oxidative stress in diabetic retinopathy , 2000, Eye.

[147]  E. Rosen,et al.  Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[148]  J. Folkman,et al.  Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. , 1989, Biochemistry.

[149]  D. Dimitrov,et al.  Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. , 1992, Biochemical and biophysical research communications.

[150]  S. Ryu,et al.  The mechanism of phospholipase C-gamma1 regulation. , 2000, Experimental & molecular medicine.

[151]  T. Nakamura,et al.  Inhibitory effect of hepatocyte growth factor against FaO hepatocellular carcinoma cells may be associated with changes of intracellular signalling pathways mediated by protein kinase C. , 1994, Research communications in molecular pathology and pharmacology.

[152]  D. Rye,et al.  Somatomedin on insulin-dependent diabetes mellitus. , 1977, The Journal of clinical endocrinology and metabolism.

[153]  P. Campochiaro,et al.  Angiopoietin 2 expression in the retina: upregulation during physiologic and pathologic neovascularization , 2000, Journal of cellular physiology.

[154]  I. Eardley,et al.  The effect of cyclic GMP on rabbit corporal smooth muscle tone and its modulation by cyclo-oxygenase products. , 2000, Prostaglandins, leukotrienes, and essential fatty acids.

[155]  J. Caro,et al.  Hypoxia regulation of gene transcription. , 2001, High altitude medicine & biology.

[156]  R. Coleman,et al.  Diacylglycerol generated in CHO cell plasma membrane by phospholipase C is used for triacylglycerol synthesis. , 2001, Journal of lipid research.

[157]  D. Edwards,et al.  Gap junctional communication underpins EDHF-type relaxations evoked by ACh in the rat hepatic artery. , 2001, American journal of physiology. Heart and circulatory physiology.

[158]  Lois E. H. Smith,et al.  Essential role of growth hormone in ischemia-induced retinal neovascularization. , 1997, Science.

[159]  D. Gospodarowicz,et al.  Cultured bovine bone cells synthesize basic fibroblast growth factor and store it in their extracellular matrix. , 1989, Endocrinology.

[160]  G. Zimmerman,et al.  The regulation of platelet-activating factor production in endothelial cells. The role of calcium and protein kinase C. , 1989, The Journal of biological chemistry.

[161]  P. Kubes,et al.  Nitric oxide: an endogenous modulator of leukocyte adhesion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[162]  T. Bek,et al.  Foveal haemorrhages in diabetic retinopathy. Clinical characteristics and visual outcome. , 2000, Acta ophthalmologica Scandinavica.

[163]  S. Bursell,et al.  Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. , 1996, Science.

[164]  C. Lundby,et al.  Acute hypoxia and hypoxic exercise induce DNA strand breaks and oxidative DNA damage in humans , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[165]  J. Matés,et al.  Antioxidant enzymes and human diseases. , 1999, Clinical biochemistry.

[166]  Minoru Yoshida,et al.  Eicosanoid profile in cultured human pulmonary artery smooth muscle cells treated with IL-1β and TNFα , 1998 .

[167]  J. Stamler,et al.  Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. , 1994, Circulation.

[168]  E S Gragoudas,et al.  Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. , 1996, Archives of ophthalmology.

[169]  J. P. De La Cruz,et al.  Effect of camonagrel, a selective thromboxane synthase inhibitor, on retinal vascularization in experimental diabetes. , 1998, European journal of pharmacology.

[170]  M. Nishikawa,et al.  Significance of Platelet-Derived Microparticles and Activated Platelets in Diabetic Nephropathy , 1999, Nephron.

[171]  G. Chader PEDF: Raising both hopes and questions in controlling angiogenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[172]  T. Lyons,et al.  Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)hydroxylysine in human skin collagen. , 1991, Biochemistry.

[173]  A. Giaccia,et al.  Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. , 1997, Blood.

[174]  J. Partanen,et al.  Analysis of Tie receptor tyrosine kinase in haemopoietic progenitor and leukaemia cells , 1997, British journal of haematology.

[175]  Daniel B. Rifkin,et al.  Fibroblast Growth Factor-2 (FGF-2) Induces Vascular Endothelial Growth Factor (VEGF) Expression in the Endothelial Cells of Forming Capillaries: An Autocrine Mechanism Contributing to Angiogenesis , 1998, The Journal of cell biology.

[176]  P. Kubes,et al.  Mediators of leukocyte adhesion in rat mesenteric venules elicited by inhibition of nitric oxide synthesis. , 1993, Gastroenterology.

[177]  K. Plate,et al.  Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. , 1998, The American journal of pathology.

[178]  K. Kawasaki,et al.  Upregulation of Retinal Vascular Endothelial Growth Factor mRNAs in Spontaneously Diabetic Rats without Ophthalmoscopic Retinopathy , 1998, Ophthalmic Research.

[179]  T. Nakamura,et al.  Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[180]  Lois E. H. Smith,et al.  Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[181]  Søren Jacob Bakke,et al.  Regional cerebral blood flow (rCBF) and cerebral vasoreactivity in patients with retinal ischaemic symptoms. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[182]  G. Paolisso,et al.  Oxidative Stress and Diabetic Vascular Complications , 1996, Diabetes Care.

[183]  A. Phillips,et al.  Decreased Degradation of Collagen and Fibronectin following Exposure of Proximal Cells to Glucose , 1999, Nephron Experimental Nephrology.

[184]  M. Aoki,et al.  Potential Role of an Endothelium-Specific Growth Factor, Hepatocyte Growth Factor, on Endothelial Damage in Diabetes , 1997, Diabetes.

[185]  N. Fausto Hepatocyte growth factor receptor and the c-met oncogene Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF, Aaronson SA. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991;251:802?804 , 1991 .

[186]  L. Rizzolo,et al.  Regulation of glucose transporters during development of the retinal pigment epithelium. , 2000, Brain research. Developmental brain research.

[187]  Ic. Michaelson,et al.  The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases , 1948 .

[188]  T. Quinn,et al.  Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[189]  H. Zhu,et al.  Yeast flavohemoglobin is an ancient protein related to globins and a reductase family. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[190]  John Calvin Reed,et al.  Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. , 2000, The American journal of pathology.

[191]  N. Matsuki,et al.  Endothelin activates the dihydropyridine-sensitive, voltage-dependent Ca2+ channel in vascular smooth muscle. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[192]  L. Levine Lactacystin stimulates arachidonic acid metabolism in rat liver cells: effects of cell density on arachidonic acid release, PGI2 production and cyclooxygenase activity. , 2000, Prostaglandins, leukotrienes, and essential fatty acids.

[193]  M. Shibuya,et al.  A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. , 1995, Oncogene.

[194]  Y. Hirata,et al.  The development of electroretinogram abnormalities and the possible role of polyol pathway activity in diabetic hyperglycemia and galactosemia. , 1988, Metabolism: clinical and experimental.

[195]  G. Camussi,et al.  Production of platelet-activating factor by chick retina. , 1986, The Journal of biological chemistry.

[196]  S. Bursell,et al.  Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor , 1996, Science.

[197]  W. Sessa,et al.  Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. , 2001, The American journal of pathology.

[198]  G. Werther,et al.  Localization of mRNAs for insulin-like growth factor-I (IGF-I), IGF-I receptor, and IGF binding proteins in rat eye. , 1996, Investigative ophthalmology & visual science.

[199]  C. Kahn,et al.  Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. , 1985, The Journal of clinical investigation.

[200]  W. Liu,et al.  LY 294002, an inhibitor of phosphatidylinositol 3-kinase, inhibits GH-mediated expression of the IGF-I gene in rat hepatocytes. , 2001, Endocrinology.

[201]  Y. Hinokio,et al.  Oxidative DNA damage in diabetes mellitus: its association with diabetic complications , 1999, Diabetologia.

[202]  H. Tritschler,et al.  Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy. , 1999, Diabetes.

[203]  T. Kern,et al.  Abnormalities of retinal metabolism in diabetes or galactosemia: ATPases and glutathione. , 1994, Investigative ophthalmology & visual science.

[204]  E. Feldman,et al.  The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. , 1994, The Journal of clinical investigation.

[205]  G. Zimmerman,et al.  Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. , 1985, The Journal of clinical investigation.

[206]  P. Vanhoutte,et al.  Heterogeneous distribution of endothelium-dependent relaxations resistant to NG-nitro-L-arginine in rats. , 1992, The American journal of physiology.

[207]  G. Schmid-Schönbein,et al.  Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. , 1991, The American journal of pathology.

[208]  J. Simons,et al.  Hypoxia-inducible factor 1α and 1β proteins share common signaling pathways in human prostate cancer cells , 2001 .

[209]  M. Boulton,et al.  Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management , 1997, The British journal of ophthalmology.

[210]  M. Shibuya,et al.  The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-γ pathway and partially induces mitotic signals in NIH3T3 fibroblasts , 1997, Oncogene.

[211]  V. Han,et al.  Modulation of insulin-like growth factor (IGF) and IGF binding protein biosynthesis by hypoxia in cultured vascular endothelial cells. , 1998, The Journal of endocrinology.

[212]  T. Nakamura,et al.  Roles of growth factors and of tumor necrosis factor-alpha on liver cell proliferation induced in rats by lead nitrate. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[213]  E. Leite,et al.  Blood-retinal barrier permeability and its relation to progression of retinopathy in patients with type 2 diabetes. A four-year follow-up study , 1993, Graefe's Archive for Clinical and Experimental Ophthalmology.

[214]  D. Granger,et al.  Role of adhesion molecules in vascular regulation and damage , 2000, Current hypertension reports.

[215]  R. Wallace,et al.  Intercellular adhesion molecule-1 gene expression in human endothelial cells. Differential regulation by tumor necrosis factor-alpha and phorbol myristate acetate. , 1992, The Journal of biological chemistry.

[216]  E. Kohner,et al.  Intracellular protein glycation in cultured retinal capillary pericytes and endothelial cells exposed to high-glucose concentration. , 1999, Cellular and molecular biology.

[217]  S. Coughlin,et al.  Signal transduction by the platelet-derived growth factor receptor. , 1988, Cold Spring Harbor symposia on quantitative biology.

[218]  E. Agardh,et al.  Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats. , 2000, Current eye research.

[219]  D. Greene,et al.  Aldose reductase gene expression and osmotic dysregulation in cultured human retinal pigment epithelial cells. , 1993, The American journal of physiology.

[220]  T. Lane,et al.  Modulation of endothelial cell expression of intercellular adhesion molecule 1 by protein kinase C activation. , 1989, Biochemical and biophysical research communications.

[221]  S. Sakakibara,et al.  Cellular mechanism of action by a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. , 1988, Biochemical and biophysical research communications.

[222]  K. Sugahara,et al.  Inhibition of activation of human peripheral blood eosinophils by Y-24180, an antagonist to platelet-activating factor receptor. , 1999, Life sciences.

[223]  H. Granger,et al.  Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[224]  J. Cunha-Vaz,et al.  The blood-retinal barrier in diabetes during puberty. , 1994, Archives of ophthalmology.

[225]  J. E. Poulsen The Houssay Phenomenon in Man: Recovery from Retinopathy in a Case of Diabetes With Simmonds' Disease , 1953, Diabetes.

[226]  H. Freyberger,et al.  Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. , 1993, The Journal of clinical investigation.

[227]  S. Husain,et al.  Role of protein kinase C alpha and mitogen-activated protein kinases in endothelin-1-stimulation of cytosolic phospholipase A2 in iris sphincter smooth muscle. , 2000, Journal of cardiovascular pharmacology.

[228]  J. Smith,et al.  Prostaglandin E2‐induced sensitization of bradykinin‐evoked responses in rat dorsal root ganglion neurons is mediated by cAMP‐dependent protein kinase A , 2000, The European journal of neuroscience.

[229]  K. Kato,et al.  VEGF-dependent signaling in retinal microvascular endothelial cells. , 1999, Fukushima journal of medical science.

[230]  B Kirchhof,et al.  Leukocyte-mediated endothelial cell injury and death in the diabetic retina. , 2001, The American journal of pathology.

[231]  Alan W. Stitt,et al.  Expression of the VEGF gene family during retinal vaso-obliteration and hypoxia. , 1999, Biochemical and biophysical research communications.

[232]  Y. Neuman,et al.  Increased expression of neutrophil and monocyte adhesion molecules LFA-1 and Mac-1 and their ligand ICAM-1 and VLA-4 throughout the acute phase of myocardial infarction: possible implications for leukocyte aggregation and microvascular plugging. , 1998, Journal of the American College of Cardiology.

[233]  S. Nomura,et al.  Cytometric analysis of high shear-induced platelet microparticles and effect of cytokines on microparticle generation. , 2000, Cytometry.

[234]  R. Simó,et al.  Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study. , 2000, Diabetes care.

[235]  J. Tombran-Tink,et al.  PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. , 1991, Experimental eye research.

[236]  M. Itoh,et al.  Exogenous Nitric Oxide Increases Neutrophil Adhesion to Cultured Human Endothelial Monolayers through a Protein Kinase G Dependent Mechanism , 1999, Inflammation.

[237]  Pamela F. Jones,et al.  Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning , 1996, Cell.

[238]  R. Levy,et al.  Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis. , 2001, The American journal of pathology.

[239]  T. Kern,et al.  Capillary lesions develop in retina rather than cerebral cortex in diabetes and experimental galactosemia. , 1996, Archives of ophthalmology.

[240]  L. Giudice,et al.  Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[241]  R. Tarnuzzer,et al.  Insulin-like growth factor: receptor and binding proteins in human retinal endothelial cell cultures of diabetic and non-diabetic origin. , 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[242]  L. Aiello,et al.  Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[243]  M. Grant,et al.  Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor , 1993, Diabetologia.

[244]  J. Flanagan,et al.  Heterodimers of Placenta Growth Factor/Vascular Endothelial Growth Factor , 1996, The Journal of Biological Chemistry.

[245]  K. Shin,et al.  Synthesis of flavonoids and their effects on aldose reductase and sorbitol accumulation in streptozotocin‐induced diabetic rat tissues , 2001, The Journal of pharmacy and pharmacology.

[246]  D. Maglione Persico MG.Isolation of a human placenta cDNA coding for a potein related to the vascular premeability factor , 1991 .

[247]  K. Preissner,et al.  Fibronectin, laminin, vitronectin and their receptors at newly-formed capillaries in proliferative diabetic retinopathy. , 1995, Experimental eye research.

[248]  N. Copeland,et al.  A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[249]  C. Heldin,et al.  Rat brain capillary endothelial cells express functional PDGF B-type receptors. , 1989, Growth factors.

[250]  R. Kaufmann,et al.  Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes. , 1998, The Journal of investigative dermatology.

[251]  M. Nomura,et al.  Placenta Growth Factor and Vascular Endothelial Growth Factor B and C Expression in Microvascular Endothelial Cells and Pericytes , 1999, The Journal of Biological Chemistry.

[252]  S. Husain,et al.  Role of protein kinase Cα and mitogen-activated protein kinases in endothelin-1-stimulation of cytosolic phospholipase A2 in iris sphincter smooth muscle , 2000 .

[253]  J. Alexander,et al.  Vascular Permeability Factor/Vascular Endothelial Cell Growth Factor-mediated Permeability Occurs through Disorganization of Endothelial Junctional Proteins* , 1998, The Journal of Biological Chemistry.

[254]  A. Ullrich,et al.  High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis , 1993, Cell.

[255]  M. Shibuya,et al.  Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. , 1990, Oncogene.

[256]  M. Burns,et al.  Retinal vessel abnormalities of phototoxic retinopathy in rats. , 1980, Investigative ophthalmology & visual science.

[257]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[258]  F. Ferris,et al.  Diabeteslike proliferative retinal changes in galactose-fed dogs , 1993 .

[259]  Carter Vb,et al.  The power of words. , 1951, Lancet.

[260]  E. Agardh,et al.  The glutathione levels are reduced in Goto-Kakizaki rat retina, but are not influenced by aminoguanidine treatment. , 1998, Current eye research.

[261]  M. Triggiani,et al.  Inhibition of platelet-activating factor synthesis in human neutrophils and platelets by propionyl-L-carnitine. , 1999, Biochemical pharmacology.

[262]  H. Drexler,et al.  Expression of hepatocyte growth factor and its receptor c-met in human leukemia-lymphoma cell lines. , 1998, Leukemia research.

[263]  J. P. De La Cruz,et al.  Effect of erythrocytes and prostacyclin production in the effect of fructose and sorbitol on platelet activation in human whole blood in vitro. , 1997, Thrombosis research.

[264]  U. Pohl,et al.  Endothelium-derived nitric oxide in the control of tissue perfusion and oxygen supply: physiological and pathophysiological implications. , 1993, European heart journal.

[265]  C. Heldin,et al.  Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[266]  D. Gospodarowicz,et al.  VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor. , 1994, Growth factors.

[267]  L. Aiello,et al.  Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factor. , 2000, The Journal of clinical investigation.

[268]  M. Boulton,et al.  Production of IGF-I and IGF binding proteins by retinal cells in vitro. , 1994, The British journal of ophthalmology.

[269]  M. Rusnati,et al.  Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form , 1989, Journal of cellular physiology.

[270]  S. Iannello,et al.  In vitro inhibition of glucose phosphorylation by an aldose-reductase inhibitor (Tolrestat) in some non-insulin-sensitive rabbit tissues. , 1999, Journal of diabetes and its complications.

[271]  Urban Deutsch,et al.  Angiopoietin-1 induces sprouting angiogenesis in vitro , 1998, Current Biology.

[272]  T. Miyahara,et al.  Endothelin-1 selectively contracts portal vein through both ETA and ETB receptors in isolated rabbit liver. , 1997, The American journal of physiology.

[273]  R. Palmer,et al.  Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[274]  M. Shibuya,et al.  A single autophosphorylation site on KDR/Flk‐1 is essential for VEGF‐A‐dependent activation of PLC‐γ and DNA synthesis in vascular endothelial cells , 2001, The EMBO journal.

[275]  P. Campochiaro,et al.  Pigment epithelium‐derived factor inhibits retinal and choroidal neovascularization , 2001, Journal of cellular physiology.